---
title: "Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286964032.md"
description: "Pfizer Inc. (PFE) shares rose 1.30% to $25.66 on a challenging trading day for the market, outperforming competitors like Johnson & Johnson and Eli Lilly. Despite the gain, Pfizer remains 10.73% below its 52-week high of $28.75. The trading volume reached 40.9 million, surpassing its 50-day average of 37.8 million."
datetime: "2026-05-19T20:36:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286964032.md)
  - [en](https://longbridge.com/en/news/286964032.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286964032.md)
---

# Pfizer Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Pfizer Inc. (PFE) rose 1.30% to $25.66 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.67% to 7,353.61 and Dow Jones Industrial Average falling 0.65% to 49,363.88.

Pfizer Inc. closed 10.73% short of its 52-week high of $28.75, which the company achieved on April 2nd.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.47% to $230.00, Eli Lilly & Co. (LLY) rose 3.37% to $1,021.41, and Abbott Laboratories (ABT) rose 1.04% to $88.82.

Trading volume (40.9 M) eclipsed its 50-day average volume of 37.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 19, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-19-26 1636ET

### Related Stocks

- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)

## Related News & Research

- [Pfizer Inc. $PFE Stock Holdings Boosted by Canada Post Corp Registered Pension Plan](https://longbridge.com/en/news/286666435.md)
- [Pfizer’s New Japan RSV Vaccine Trial Signals Ongoing Expansion for PFE](https://longbridge.com/en/news/286445564.md)
- [European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors | PFE Stock News](https://longbridge.com/en/news/286244385.md)
- [Pfizer Hemophilia Drug Win In Europe Adds Weight To Undervalued Thesis](https://longbridge.com/en/news/286344524.md)
- [Arvinas Q1 sales miss estimates on lower collaboration revenue from Pfizer](https://longbridge.com/en/news/286087618.md)